Cervantes, Phrillyn N.

HRN: 20-86-86  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2023
AMPICILLIN 250MG (VIAL)
01/06/2023
01/13/2023
IVT
228mg
Q6
Pcap C
Waiting Final Action 
01/08/2023
CEFTRIAXONE 1G (VIAL)
01/08/2023
01/14/2023
IVT
900mg
OD
Aspiration Pneumonia
Waiting Final Action 
01/21/2023
CIPROFLOXACIN 500MG (TAB)
01/21/2023
01/27/2023
ORAL
110mg
BID
Pcap
Waiting Final Action 
01/21/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
01/21/2023
01/27/2023
ORAL
3ml
Bid
Pcap
Waiting Final Action 
01/21/2023
CEFTAZIDIME 1GM (VIAL)
01/21/2023
01/27/2023
IV
450mg
Q8
HAP
Waiting Final Action 
01/21/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/21/2023
01/27/2023
IV
135mg
Q24
HAP
Waiting Final Action 
01/21/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/21/2023
01/27/2023
IV
70mg
Q6
HAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: